世界の女性健康療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Women Health Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z6082
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、女性健康療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（閉経、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、不妊症、婦人科がん）、用途別市場規模（診断及び画像センター、病院及び診療所、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・女性健康療法の市場動向
・企業の競争状況、市場シェア
・女性健康療法の種類別市場規模（閉経、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、不妊症、婦人科がん）
・女性健康療法の用途別市場規模（診断及び画像センター、病院及び診療所、在宅医療）
・女性健康療法の北米市場規模2016-2027（アメリカ、カナダ）
・女性健康療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・女性健康療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・女性健康療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・女性健康療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Abbott、Pfizer、Eli Lilly、Bayer、Merck、Roche、Novo Nordisk、Oasmia、Sanofi、Takeda、Allergan）
・結論

Market Analysis and Insights: Global Women Health Therapeutics Market
The global Women Health Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Women Health Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Women Health Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Women Health Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Women Health Therapeutics market.

Global Women Health Therapeutics Scope and Market Size
Women Health Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Women Health Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Menopause
Endometriosis
Postmenopausal osteoporosis
Breast cancer
Polycystic ovary syndrome
Infertility
Gynecological cancer

Segment by Application
Diagnostic and imaging centers
Hospitals and clinics
Home care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Abbott
Pfizer
Eli Lilly
Bayer
Merck
Roche
Novo Nordisk
Oasmia
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women Health Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Menopause
1.2.3 Endometriosis
1.2.4 Postmenopausal osteoporosis
1.2.5 Breast cancer
1.2.6 Polycystic ovary syndrome
1.2.7 Infertility
1.2.8 Gynecological cancer
1.3 Market by Application
1.3.1 Global Women Health Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic and imaging centers
1.3.3 Hospitals and clinics
1.3.4 Home care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Women Health Therapeutics Market Perspective (2016-2027)
2.2 Women Health Therapeutics Growth Trends by Regions
2.2.1 Women Health Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Women Health Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Women Health Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Women Health Therapeutics Industry Dynamic
2.3.1 Women Health Therapeutics Market Trends
2.3.2 Women Health Therapeutics Market Drivers
2.3.3 Women Health Therapeutics Market Challenges
2.3.4 Women Health Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Women Health Therapeutics Players by Revenue
3.1.1 Global Top Women Health Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Women Health Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Women Health Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Women Health Therapeutics Revenue
3.4 Global Women Health Therapeutics Market Concentration Ratio
3.4.1 Global Women Health Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women Health Therapeutics Revenue in 2020
3.5 Women Health Therapeutics Key Players Head office and Area Served
3.6 Key Players Women Health Therapeutics Product Solution and Service
3.7 Date of Enter into Women Health Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Women Health Therapeutics Breakdown Data by Type
4.1 Global Women Health Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Women Health Therapeutics Forecasted Market Size by Type (2022-2027)

5 Women Health Therapeutics Breakdown Data by Application
5.1 Global Women Health Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Women Health Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Women Health Therapeutics Market Size (2016-2027)
6.2 North America Women Health Therapeutics Market Size by Type
6.2.1 North America Women Health Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Women Health Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Women Health Therapeutics Market Size by Type (2016-2027)
6.3 North America Women Health Therapeutics Market Size by Application
6.3.1 North America Women Health Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Women Health Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Women Health Therapeutics Market Size by Application (2016-2027)
6.4 North America Women Health Therapeutics Market Size by Country
6.4.1 North America Women Health Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Women Health Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Women Health Therapeutics Market Size (2016-2027)
7.2 Europe Women Health Therapeutics Market Size by Type
7.2.1 Europe Women Health Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Women Health Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Women Health Therapeutics Market Size by Type (2016-2027)
7.3 Europe Women Health Therapeutics Market Size by Application
7.3.1 Europe Women Health Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Women Health Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Women Health Therapeutics Market Size by Application (2016-2027)
7.4 Europe Women Health Therapeutics Market Size by Country
7.4.1 Europe Women Health Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Women Health Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Women Health Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Women Health Therapeutics Market Size by Type
8.2.1 Asia-Pacific Women Health Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Women Health Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Women Health Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Women Health Therapeutics Market Size by Application
8.3.1 Asia-Pacific Women Health Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Women Health Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Women Health Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Women Health Therapeutics Market Size by Region
8.4.1 Asia-Pacific Women Health Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Women Health Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Women Health Therapeutics Market Size (2016-2027)
9.2 Latin America Women Health Therapeutics Market Size by Type
9.2.1 Latin America Women Health Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Women Health Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Women Health Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Women Health Therapeutics Market Size by Application
9.3.1 Latin America Women Health Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Women Health Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Women Health Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Women Health Therapeutics Market Size by Country
9.4.1 Latin America Women Health Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Women Health Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Women Health Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Women Health Therapeutics Market Size by Type
10.2.1 Middle East & Africa Women Health Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Women Health Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Women Health Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Women Health Therapeutics Market Size by Application
10.3.1 Middle East & Africa Women Health Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Women Health Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Women Health Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Women Health Therapeutics Market Size by Country
10.4.1 Middle East & Africa Women Health Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Women Health Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Women Health Therapeutics Introduction
11.1.4 Novartis Revenue in Women Health Therapeutics Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Women Health Therapeutics Introduction
11.2.4 Abbott Revenue in Women Health Therapeutics Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Women Health Therapeutics Introduction
11.3.4 Pfizer Revenue in Women Health Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Women Health Therapeutics Introduction
11.4.4 Eli Lilly Revenue in Women Health Therapeutics Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Women Health Therapeutics Introduction
11.5.4 Bayer Revenue in Women Health Therapeutics Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Women Health Therapeutics Introduction
11.6.4 Merck Revenue in Women Health Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Women Health Therapeutics Introduction
11.7.4 Roche Revenue in Women Health Therapeutics Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Women Health Therapeutics Introduction
11.8.4 Novo Nordisk Revenue in Women Health Therapeutics Business (2016-2021)
11.8.5 Novo Nordisk Recent Development
11.9 Oasmia
11.9.1 Oasmia Company Details
11.9.2 Oasmia Business Overview
11.9.3 Oasmia Women Health Therapeutics Introduction
11.9.4 Oasmia Revenue in Women Health Therapeutics Business (2016-2021)
11.9.5 Oasmia Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Women Health Therapeutics Introduction
11.10.4 Sanofi Revenue in Women Health Therapeutics Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Takeda
11.11.1 Takeda Company Details
11.11.2 Takeda Business Overview
11.11.3 Takeda Women Health Therapeutics Introduction
11.11.4 Takeda Revenue in Women Health Therapeutics Business (2016-2021)
11.11.5 Takeda Recent Development
11.12 Allergan
11.12.1 Allergan Company Details
11.12.2 Allergan Business Overview
11.12.3 Allergan Women Health Therapeutics Introduction
11.12.4 Allergan Revenue in Women Health Therapeutics Business (2016-2021)
11.12.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Women Health Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Menopause
Table 3. Key Players of Endometriosis
Table 4. Key Players of Postmenopausal osteoporosis
Table 5. Key Players of Breast cancer
Table 6. Key Players of Polycystic ovary syndrome
Table 7. Key Players of Infertility
Table 8. Key Players of Gynecological cancer
Table 9. Global Women Health Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Women Health Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Women Health Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Women Health Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Women Health Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Women Health Therapeutics Market Share by Regions (2022-2027)
Table 15. Women Health Therapeutics Market Trends
Table 16. Women Health Therapeutics Market Drivers
Table 17. Women Health Therapeutics Market Challenges
Table 18. Women Health Therapeutics Market Restraints
Table 19. Global Women Health Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Women Health Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Women Health Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Therapeutics as of 2020)
Table 22. Ranking of Global Top Women Health Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Women Health Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Women Health Therapeutics Product Solution and Service
Table 26. Date of Enter into Women Health Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Women Health Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Women Health Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Women Health Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Women Health Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Women Health Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Women Health Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Women Health Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Women Health Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Women Health Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Women Health Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Women Health Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Women Health Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Women Health Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Women Health Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Women Health Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Women Health Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Women Health Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Women Health Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Women Health Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Women Health Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Women Health Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Women Health Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Women Health Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Women Health Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Women Health Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Women Health Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Women Health Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Women Health Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Women Health Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Women Health Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Women Health Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Women Health Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Women Health Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Women Health Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Women Health Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Women Health Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Women Health Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Women Health Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Women Health Therapeutics Product
Table 69. Novartis Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Women Health Therapeutics Product
Table 74. Abbott Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Women Health Therapeutics Product
Table 79. Pfizer Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Women Health Therapeutics Product
Table 84. Eli Lilly Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Eli Lilly Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Women Health Therapeutics Product
Table 89. Bayer Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Women Health Therapeutics Product
Table 94. Merck Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Women Health Therapeutics Product
Table 99. Roche Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Novo Nordisk Company Details
Table 102. Novo Nordisk Business Overview
Table 103. Novo Nordisk Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Novo Nordisk Recent Development
Table 105. Oasmia Company Details
Table 106. Oasmia Business Overview
Table 107. Oasmia Women Health Therapeutics Product
Table 108. Oasmia Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Oasmia Recent Development
Table 110. Sanofi Company Details
Table 111. Sanofi Business Overview
Table 112. Sanofi Women Health Therapeutics Product
Table 113. Sanofi Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Sanofi Recent Development
Table 115. Takeda Company Details
Table 116. Takeda Business Overview
Table 117. Takeda Women Health Therapeutics Product
Table 118. Takeda Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Takeda Recent Development
Table 120. Allergan Company Details
Table 121. Allergan Business Overview
Table 122. Allergan Women Health Therapeutics Product
Table 123. Allergan Revenue in Women Health Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Allergan Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women Health Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Menopause Features
Figure 3. Endometriosis Features
Figure 4. Postmenopausal osteoporosis Features
Figure 5. Breast cancer Features
Figure 6. Polycystic ovary syndrome Features
Figure 7. Infertility Features
Figure 8. Gynecological cancer Features
Figure 9. Global Women Health Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Diagnostic and imaging centers Case Studies
Figure 11. Hospitals and clinics Case Studies
Figure 12. Home care Case Studies
Figure 13. Women Health Therapeutics Report Years Considered
Figure 14. Global Women Health Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Women Health Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Women Health Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Women Health Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Women Health Therapeutics Market Share by Players in 2020
Figure 19. Global Top Women Health Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Women Health Therapeutics Revenue in 2020
Figure 21. Global Women Health Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Women Health Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Women Health Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Women Health Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Women Health Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Women Health Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Women Health Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Women Health Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Women Health Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Women Health Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Women Health Therapeutics Market Share by Region (2016-2027)
Figure 43. China Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Women Health Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Women Health Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Women Health Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Women Health Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Women Health Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Women Health Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Women Health Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Novartis Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 69. Novo Nordisk Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 70. Oasmia Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 71. Sanofi Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 72. Takeda Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 73. Allergan Revenue Growth Rate in Women Health Therapeutics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界の女性健康療法市場規模・現状・予測（2021年-2027年）

Global Women Health Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z6082 2021年4月 95Pages
QYResearch社発行の本調査資料では、女性健康療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（閉経、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、不妊症、婦人科がん）、用途別市場規模（診断及び画像センター、病院及び診療所、在...

世界の女性健康管理市場規模・現状・予測（2021年-2027年）

Global Women Health Care Market Size, Status and Forecast 2021-2027
QYR2104Z6078 2021年4月 91Pages
QYResearch社発行の本調査資料では、女性健康管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デノスマブ、ラロキシフェン、レボノルゲストレル、ゾレドロン酸、リセドロン酸、その他）、用途別市場規模（女性不妊症、閉経後骨粗鬆症、子宮内膜症...

世界の女性健康管理市場規模・現状・予測（2021年-2027年）

世界の女性健康診断市場規模・現状・予測（2021年-2027年）

Global Women Health Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z6079 2021年4月 132Pages
QYResearch社発行の本調査資料では、女性健康診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニング及び保因者検査、超音波検...

世界の女性健康画像機器市場規模・現状・予測（2021年-2027年）

Global Women Health Imaging Equipment Market Size, Status and Forecast 2021-2027
QYR2104Z6080 2021年4月 91Pages
QYResearch社発行の本調査資料では、女性健康画像機器のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（骨密度検査、マンモグラフィ、乳房生検、超音波、その他）、用途別市場規模（病院研究所・診断研究所、学術研究所、その他）、主要地域別市場規模...

世界の女性健康リハビリテーション製品市場規模・現状・予測（2021年-2027年）

Global Women Health Rehabilitation Products Market Size, Status and Forecast 2021-2027
QYR2104Z6081 2021年4月 131Pages
QYResearch社発行の本調査資料では、女性健康リハビリテーション製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（整形外科、尿失禁、乳がん、妊娠・産後ケア、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメ...

世界の女性健康＆美容サプリメント市場規模・現状・予測（2021年-2027年）

Global Women Health and Beauty Supplement Market Size, Status and Forecast 2021-2027
QYR2104Z6077 2021年4月 128Pages
QYResearch社発行の本調査資料では、女性健康＆美容サプリメントのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミン、ミネラル、酵素、植物、タンパク質、オメガ-3、プロバイオティクス、その他）、用途別市場規模（出生前、出生後、月経前症...

世界のデジタル治療市場規模・現状・予測（2021年-2027年）

Global Digital Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z1890 2021年4月 93Pages
QYResearch社発行の本調査資料では、デジタル治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ソフトウェア、装置）、用途別市場規模（糖尿病、肥満、心血管疾患（CVD）、中枢神経系（CNS）疾患、胃腸障害（GID）、呼吸器疾患、禁煙、そ...

世界の女性健康治療市場 2021：企業別、地域別、種類・用途別

Global Women’s Health Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z15201 2021年4月 106Pages
当調査資料では、女性健康治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。女性健康治療の種類別市場規模（感染症、妊娠、腫瘍）、用途別市場規模（20歳以下、20〜50歳、50歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南...

世界の網膜静脈閉塞症治療薬市場規模・現状・予測（2021年-2027年）

Global Retinal Vein Occlusion Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5023 2021年4月 92Pages
QYResearch社発行の本調査資料では、網膜静脈閉塞症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（枝網膜静脈閉塞、網膜中心静脈閉塞症）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の女性健康療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Women Health Therapeutics Market The global Women Health Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
世界の女性健康管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Women Health Care Market The global Women Health Care market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の女性健康管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Women Health Care Market The global Women Health Care market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の閉経後骨粗鬆症治療薬市場規模・現状・予測（2021年-2027年） Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. Market Analysis a…
世界の閉経後骨粗鬆症治療薬市場規模・現状・予測（2021年-2027年） Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. Market Analysis a…